Introduction of Novel Liquid Biopsy in Genomic Medicine

Introduction of Novel Liquid Biopsy in Genomic Medicine - Novel Liquid Biopsy in Genomic Medicine

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056739

Enrollment

Registered

2026-01-20

Start date

2024-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumor Healthy person

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ?Patients or healthy persons visiting Seta Clinic Tokyo who wish to undergo "DNA CT" or "ai-CANCERCH" testing. ?Patients or healthy persons who, after having been fully informed of the study and with sufficient understanding, have given their free and voluntary written consent to participate in the study.

Exclusion criteria

Exclusion criteria: ?Patients or healthy persons who are judged to be inappropriate as test subjects by the Principal Investigator or Research Assistants.

Design outcomes

Primary

Measure	Time frame
Operational evaluation of two types of liquid biopsy	—

Countries

Japan

Contacts

Public ContactHiroshi Ibe

Seta Clinic Tokyo Center for Clinical Trials and Research

citeg@j-immunother.com03-5244-5751

Outcome results